Mondaq Canada: Intellectual Property > Patent
Bereskin & Parr LLP
If a competitor files a patent application in the patent office on an unpatentable invention, the patent office should do its job and reject the patent application.
Gowling WLG
On September 21, 2017, the Certificate of Supplementary Protection Regulations ("CSP Regulations") came into force ...
Oyen Wiggs Green & Mutala
A regular patent application requires carefully and thoroughly drafting a patent specification and claims, and is best prepared with the assistance of a patent agent.
Osler, Hoskin & Harcourt LLP
CRISPR-Cas9 is a technology with the potential for an unimaginable impact on society. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) allows scientists to edit genomes in living organisms at the cellular level by guiding a "scissor-like" protein to targeted sections of DNA within a cell, and then prompting it to alter or "edit" the DNA in some way.
Oyen Wiggs Green & Mutala
Despite extensive discussion by our courts, the reasons behind why such a prohibition exists remain unclear for both courts and patent lawyers.
McCarthy Tétrault LLP
The Defendants brought a motion to strike the Plaintiff's Statement of Claim.
Bereskin & Parr LLP
The vast majority1 of Canadian patents currently in force carry a term limited to twenty years from the filing date. However, as part of Canada's obligations under CETA2 certain patents relating to drugs authorized ...
Bereskin & Parr LLP
The vast majority of IP litigants in Canada already make the Federal Court their choice of forum.
Smart & Biggar/Fetherstonhaugh
Patented Medicine Prices Review Board releases August 2018 NEWSletter.
Smart & Biggar/Fetherstonhaugh
The Report includes information regarding trends in listing on the Patent Register and the Register of Innovative Drugs, as well as related court activity.
Bereskin & Parr LLP
In one of the first actions brought under the amended Patented Medicines (Notice of Compliance) Regulations ("Regulations"), Genentech and Roche sued Amgen for infringement over its KANJINTI product ...
Aitken Klee
As the parties had already reached agreement regarding matters of liability and quantification of damages, the trial only concerned Millennium's claim for infringement of three patents and Teva's defences based on non-infringement and invalidity.
Smart & Biggar/Fetherstonhaugh
The Court concluded that both claims were obvious and that the 936 Patent failed to meet the criteria for a valid selection patent.
Smart & Biggar/Fetherstonhaugh
Justice Manson found the claims were obvious
Smart & Biggar/Fetherstonhaugh
Rather, the Court's role is to determine whether the plaintiff raises an arguable case such that it is not plain and obvious the action will fail.
ROBIC
In an earlier article (Blockchain. What is it and what are its IP issues?), we provided an introduction to blockchain technologies and explored some of the IP issues surrounding this emerging field.
ROBIC
An inventor to a patent is someone who makes an inventive contribution to the invention as claimed in one of the claims of that patent.
Aird & Berlis LLP
The FIQ claims to be a non-profit corporation that holds itself out as an inexpensive alternative to conventional patent agencies.
Aird & Berlis LLP
As a patent practitioner, one of the questions I often get asked is whether distributed ledger technology (DLT), such as blockchain, is patentable.
Bereskin & Parr LLP
Most third party challenges to patentability occur in front of national or regional patent offices. WIPO recently released a summary of data regarding the extent to which third parties are challenging
Latest Video
Most Popular Recent Articles
Norton Rose Fulbright Canada LLP
Supercluster or cluster is a reference to research by economists Michael Porter around what makes communities competitive and especially innovative communities.
Norton Rose Fulbright Canada LLP
In these videos, we look at the supercluster concept and how these superclusters will support frictionless IP as well create and monetize data in Canada.
Smart & Biggar/Fetherstonhaugh
Patented Medicine Prices Review Board releases August 2018 NEWSletter.
Bereskin & Parr LLP
The vast majority1 of Canadian patents currently in force carry a term limited to twenty years from the filing date. However, as part of Canada's obligations under CETA2 certain patents relating to drugs authorized ...
Aitken Klee
As the parties had already reached agreement regarding matters of liability and quantification of damages, the trial only concerned Millennium's claim for infringement of three patents and Teva's defences based on non-infringement and invalidity.
Oyen Wiggs Green & Mutala
Despite extensive discussion by our courts, the reasons behind why such a prohibition exists remain unclear for both courts and patent lawyers.
Aird & Berlis LLP
As a patent practitioner, one of the questions I often get asked is whether distributed ledger technology (DLT), such as blockchain, is patentable.
Smart & Biggar/Fetherstonhaugh
The Court concluded that both claims were obvious and that the 936 Patent failed to meet the criteria for a valid selection patent.
Smart & Biggar/Fetherstonhaugh
Justice Manson found the claims were obvious
Bereskin & Parr LLP
The vast majority of IP litigants in Canada already make the Federal Court their choice of forum.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with